highlighter [ highlighting marker | highlighting pen | highlighter pen ]

underscore character [ word underscore character ]

stress the need

continuous underline | single underlining

nanotag | nanolabel | nanomarker | fluorescent nanotag | fluorescent nanolabel | fluorescent nanomarker

marker chromosome

tag

14. Encourages all the Member States to engage actively in the definition, development and implementation of common protocols for early diagnosis, to establish biomarkers with a view to building on the emergence of new therapies for both dementia and pre-dementia, and to define a common research agenda in the field of neurodegenerative diseases and the sharing of best practices in the area of research into neurodegenerative diseases, thus reducing the prevailing inequalities between Member States and within Member States as regards diagnosis and treatment; points out that standard operational procedures for the assessment of disease mar ...[+++]kers will be key to drug discovery and to the development of more effective, technology-assisted care of patients with Alzheimer's disease;

14. Encourages all the Member States to engage actively in the definition, development and implementation of common protocols for early diagnosis, to establish biomarkers with a view to building on the emergence of new therapies for both dementia and pre-dementia, and to define a common research agenda in the field of neurodegenerative diseases and the sharing of best practices in the area of research into neurodegenerative diseases, thus reducing the prevailing inequalities between Member States and within Member States as regards diagnosis and treatment; points out that standard operational procedures for the assessment of disease mar ...[+++]kers will be key to drug discovery and to the development of more effective, technology-assisted care of patients with Alzheimer's disease;

14. Encourages all the Member States to engage actively in the definition, development and implementation of common protocols for early diagnosis, to establish biomarkers with a view to building on the emergence of new therapies for both dementia and pre-dementia, and to define a common research agenda in the field of neurodegenerative diseases and the sharing of best practices in the area of research into neurodegenerative diseases, thus reducing the prevailing inequalities between Member States and within Member States as regards diagnosis and treatment; points out that standard operational procedures for the assessment of disease mar ...[+++]kers will be key to drug discovery and to the development of more effective, technology-assisted care of patients with Alzheimer’s disease;

I, in my capacity as a veterinarian, have very frequently been called in, in Lower Saxony and elsewhere, to deal with outbreaks of animal diseases, and I know that the right way to go about a vaccination policy is with marker vaccines – I emphasise that they have to be marker vaccines if at all possible – and this is also, I believe, an approach that is in line with what the enthusiasts for animal welfare would have us do.